|
|
 |
|
Viewing report
|
|
|
|
Pharmaceutical and Healthcare Market in Poland 2009 - Development Forecasts for 2009-2011 (Polish Version)
PMR Ltd, June 2009, Pages: 291
'As in other years, this year’s edition of our pharmaceutical and healthcare market report delivers a comprehensive overview on the Polish pharmaceutical market, with information on current and anticipated trends, market value and events, as well as forecasts for market growth, for the entire market and by the individual drug categories. We have also reviewed the most recent regulatory changes and their market impact, including the amandments to Pharmaceutical Act and reimbursement lists; we’ve also estimated the market consequences of the upcoming amendments.'
- Monika Stefanczyk, Head Pharmaceutical Market Analyst
- Agnieszka Stawarska, Pharmaceutical Market Analyst
The report comprises the complete economic analysis of pharmaceutical sector in Poland as well as recent data on healthcare sector in the region and contains forecast projections for 2009-2011.
The value data are presented for the total market, pharmacy and hospital segment, Rx, foreign and domestic drugs, generic and innovative medicines, and main ATC categories together with forecasts.
The report offers insights into ongoing trends, taking a closer look at areas of growth and decline. Factors that influence the market, from epidemiology to consumer behaviour, are studied and presented for your thorough understanding of the market. Economic data, such as employment and cost-revenue analysis of the pharmaceutical sector, are also covered.
Our analysis also takes into account the latest changes in reimbursement and legislation (latest and expected). The impact of global financial crisis has also been analysed and taken into consideration in the forecasts provided for the size of the Polish pharmaceutical and healthcare market by the PMR team of pharmaceutical analysts and economists.
If you are looking for:
- detailed information on legal environment together with most important changes in the “minor” and “major” ??amendments to the Pharmaceutical Act, analysis of changes is Act on Healthcare Services Financed from Public Funds
- analysis of latest novelisations of reimbursement lists and their impact on the market??
- profiles of largest players active on pharma market ??
- strategic key data ??
- data needed for market entry??
- description of epidemiologic and demographic trends??
- economic trends analysis??
- consumer behaviour in Poland analysis
This title is also available in the following language
Pharmaceutical and Healthcare Market in Poland 2009 - Development Forecasts for 2009-2011 (English Version)
Customers who bought this item also bought
Pharmaceutical and Healthcare Market in Poland 2007 - Development Forecasts for 2007-2009
Pharmaceutical and Healthcare Market in Poland 2007 - Development Forecasts for 2007-2009
Pharmaceutical and Healthcare Market in Poland 2009 - Development Forecasts for 2009-2011
Special Report: Key Pricing and Reimbursement Trends for CNS Drugs
Non-pharmacy OTC Market in Poland 2008. Development Forecasts for 2008-2010
Non-pharmacy OTC Market in Poland 2008. Development Forecasts for 2008-2010
Strategic Overview of Pharmaceutical Pricing and Reimbursement in the Major Markets
Infectious Diseases Drugs Markets
The Pricing and Reimbursement Environment for Neurology Drugs
Pharmaceutical Pricing and Reimbursement in Italy, 2008
Special Report: Pharmaceutical Pricing and Reimbursement in Germany, 2008
Pharmaceutical Pricing and Reimbursement in France, 2008
|
|
|
|
